GENEDX HOLDINGS CORP (WGS) Stock Fundamental Analysis
NASDAQ:WGS - US81663L2007 - Common Stock
129 USD
-0.19 (-0.15%)
126.01 USD
-2.99 (-2.32%)
Taking everything into account, WGS scores 5 out of 10 in our fundamental rating. WGS was compared to 101 industry peers in the Health Care Providers & Services industry. WGS has a great financial health rating, but its profitability evaluates not so good. WGS is valued quite expensive, but it does show an excellent growth.
1. Profitability
1.1 Basic Checks
WGS had positive earnings in the past year.
WGS had a positive operating cash flow in the past year.
WGS had negative earnings in each of the past 5 years.
WGS had a negative operating cash flow in each of the past 5 years.
1.2 Ratios
WGS has a Return On Assets of 0.30%. This is comparable to the rest of the industry: WGS outperforms 48.51% of its industry peers.
WGS has a Return On Equity (0.51%) which is comparable to the rest of the industry.
WGS has a Return On Invested Capital (1.09%) which is in line with its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.3% | ||
| ROE | 0.51% | ||
| ROIC | 1.09% |
ROA(3y)-55.43%
ROA(5y)-61.29%
ROE(3y)-104.93%
ROE(5y)-1172.42%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
WGS has a Profit Margin (0.39%) which is comparable to the rest of the industry.
Looking at the Operating Margin, with a value of 1.50%, WGS is in line with its industry, outperforming 46.53% of the companies in the same industry.
The Gross Margin of WGS (67.18%) is better than 86.14% of its industry peers.
In the last couple of years the Gross Margin of WGS has grown nicely.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 1.5% | ||
| PM (TTM) | 0.39% | ||
| GM | 67.18% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5Y10.27%
2. Health
2.1 Basic Checks
WGS has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for WGS has been increased compared to 1 year ago.
The number of shares outstanding for WGS has been increased compared to 5 years ago.
The debt/assets ratio for WGS has been reduced compared to a year ago.
2.2 Solvency
An Altman-Z score of 9.00 indicates that WGS is not in any danger for bankruptcy at the moment.
WGS has a better Altman-Z score (9.00) than 93.07% of its industry peers.
The Debt to FCF ratio of WGS is 62.27, which is on the high side as it means it would take WGS, 62.27 years of fcf income to pay off all of its debts.
WGS has a Debt to FCF ratio of 62.27. This is comparable to the rest of the industry: WGS outperforms 40.59% of its industry peers.
WGS has a Debt/Equity ratio of 0.19. This is a healthy value indicating a solid balance between debt and equity.
With a decent Debt to Equity ratio value of 0.19, WGS is doing good in the industry, outperforming 69.31% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.19 | ||
| Debt/FCF | 62.27 | ||
| Altman-Z | 9 |
ROIC/WACC0.12
WACC8.85%
2.3 Liquidity
WGS has a Current Ratio of 2.87. This indicates that WGS is financially healthy and has no problem in meeting its short term obligations.
WGS has a Current ratio of 2.87. This is amongst the best in the industry. WGS outperforms 85.15% of its industry peers.
A Quick Ratio of 2.70 indicates that WGS has no problem at all paying its short term obligations.
Looking at the Quick ratio, with a value of 2.70, WGS belongs to the top of the industry, outperforming 85.15% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.87 | ||
| Quick Ratio | 2.7 |
3. Growth
3.1 Past
WGS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 173.71%, which is quite impressive.
WGS shows a strong growth in Revenue. In the last year, the Revenue has grown by 48.70%.
The Revenue has been growing by 9.26% on average over the past years. This is quite good.
EPS 1Y (TTM)173.71%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%600%
Revenue 1Y (TTM)48.7%
Revenue growth 3Y12.91%
Revenue growth 5Y9.26%
Sales Q2Q%45.63%
3.2 Future
The Earnings Per Share is expected to grow by 86.80% on average over the next years. This is a very strong growth
Based on estimates for the next years, WGS will show a very strong growth in Revenue. The Revenue will grow by 20.98% on average per year.
EPS Next Y579.55%
EPS Next 2Y193%
EPS Next 3Y142.94%
EPS Next 5Y86.8%
Revenue Next Year41.55%
Revenue Next 2Y29.49%
Revenue Next 3Y25.65%
Revenue Next 5Y20.98%
3.3 Evolution
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
WGS is valuated quite expensively with a Price/Earnings ratio of 90.21.
WGS's Price/Earnings ratio is in line with the industry average.
The average S&P500 Price/Earnings ratio is at 27.17. WGS is valued rather expensively when compared to this.
With a Price/Forward Earnings ratio of 65.33, WGS can be considered very expensive at the moment.
The rest of the industry has a similar Price/Forward Earnings ratio as WGS.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.78, WGS is valued quite expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 90.21 | ||
| Fwd PE | 65.33 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of WGS indicates a slightly more expensive valuation: WGS is more expensive than 64.36% of the companies listed in the same industry.
WGS's Price/Free Cash Flow ratio is in line with the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 4465.26 | ||
| EV/EBITDA | 123.75 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
WGS's earnings are expected to grow with 142.94% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.16
PEG (5Y)N/A
EPS Next 2Y193%
EPS Next 3Y142.94%
5. Dividend
5.1 Amount
No dividends for WGS!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
129
-0.19 (-0.15%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners104.48%
Inst Owner Change9.85%
Ins Owners1.59%
Ins Owner Change0.55%
Market Cap3.71B
Analysts83.64
Price Target117.59 (-8.84%)
Short Float %14.58%
Short Ratio3.92
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)375.13%
Min EPS beat(2)364.92%
Max EPS beat(2)385.34%
EPS beat(4)4
Avg EPS beat(4)286.61%
Min EPS beat(4)118.42%
Max EPS beat(4)385.34%
EPS beat(8)8
Avg EPS beat(8)163.97%
EPS beat(12)9
Avg EPS beat(12)102.26%
EPS beat(16)11
Avg EPS beat(16)69.88%
Revenue beat(2)2
Avg Revenue beat(2)12.92%
Min Revenue beat(2)6.85%
Max Revenue beat(2)18.99%
Revenue beat(4)4
Avg Revenue beat(4)14.53%
Min Revenue beat(4)6.85%
Max Revenue beat(4)18.99%
Revenue beat(8)8
Avg Revenue beat(8)12.68%
Revenue beat(12)11
Avg Revenue beat(12)9.63%
Revenue beat(16)14
Avg Revenue beat(16)5.31%
PT rev (1m)10.25%
PT rev (3m)19.26%
EPS NQ rev (1m)32.82%
EPS NQ rev (3m)23.19%
EPS NY rev (1m)44.96%
EPS NY rev (3m)41.65%
Revenue NQ rev (1m)12.12%
Revenue NQ rev (3m)12.93%
Revenue NY rev (1m)11.42%
Revenue NY rev (3m)11.69%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 90.21 | ||
| Fwd PE | 65.33 | ||
| P/S | 10.23 | ||
| P/FCF | 4465.26 | ||
| P/OCF | 284.56 | ||
| P/B | 13.37 | ||
| P/tB | 42.35 | ||
| EV/EBITDA | 123.75 |
EPS(TTM)1.43
EY1.11%
EPS(NY)1.97
Fwd EY1.53%
FCF(TTM)0.03
FCFY0.02%
OCF(TTM)0.45
OCFY0.35%
SpS12.61
BVpS9.65
TBVpS3.05
PEG (NY)0.16
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.3% | ||
| ROE | 0.51% | ||
| ROCE | 1.38% | ||
| ROIC | 1.09% | ||
| ROICexc | 1.66% | ||
| ROICexgc | 6.29% | ||
| OM | 1.5% | ||
| PM (TTM) | 0.39% | ||
| GM | 67.18% | ||
| FCFM | 0.23% |
ROA(3y)-55.43%
ROA(5y)-61.29%
ROE(3y)-104.93%
ROE(5y)-1172.42%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5Y10.27%
F-Score8
Asset Turnover0.78
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.19 | ||
| Debt/FCF | 62.27 | ||
| Debt/EBITDA | 1.8 | ||
| Cap/Depr | 52.21% | ||
| Cap/Sales | 3.37% | ||
| Interest Coverage | 0.93 | ||
| Cash Conversion | 45.24% | ||
| Profit Quality | 59.03% | ||
| Current Ratio | 2.87 | ||
| Quick Ratio | 2.7 | ||
| Altman-Z | 9 |
F-Score8
WACC8.85%
ROIC/WACC0.12
Cap/Depr(3y)22.03%
Cap/Depr(5y)86.79%
Cap/Sales(3y)3.57%
Cap/Sales(5y)7.67%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)173.71%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%600%
EPS Next Y579.55%
EPS Next 2Y193%
EPS Next 3Y142.94%
EPS Next 5Y86.8%
Revenue 1Y (TTM)48.7%
Revenue growth 3Y12.91%
Revenue growth 5Y9.26%
Sales Q2Q%45.63%
Revenue Next Year41.55%
Revenue Next 2Y29.49%
Revenue Next 3Y25.65%
Revenue Next 5Y20.98%
EBIT growth 1Y106.43%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year586.36%
EBIT Next 3Y145.14%
EBIT Next 5YN/A
FCF growth 1Y100.31%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y104.97%
OCF growth 3YN/A
OCF growth 5YN/A